EyePoint Pharmaceuticals's total assets for Q1 2026 were $288.22M, a decrease of -20.82% from the previous quarter. EYPT total liabilities were $57.74M for the fiscal quarter, a -0.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.